Research
Researchers found that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help overcome a long-standing barrier in early-stage prostate cancer treatment.
Latest stories
Research
October 11, 2024
Individualized Medicine
October 9, 2024
Discovery Science
October 9, 2024
Cardiovascular
October 8, 2024
Clinical Trials
October 2, 2024
Research
Mayo Clinic secures ARPA-H award to build a living pharmacy within the body for inflammatory disease
October 2, 2024
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community